ZVSA
Price:
$0.195
Market Cap:
$1.58M
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Industry
Biotechnology
IPO Date
2022-02-11
Stock Exchange
OTC
Ticker
ZVSA
According to ZyVersa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 898.92M. This represents a change of 10.39% compared to the average of 814.32M of the last 4 quarters.
The mean historical Enterprise Value of ZyVersa Therapeutics, Inc. over the last ten years is 172.73M. The current 898.92M Enterprise Value has changed 51.94% with respect to the historical average. Over the past ten years (40 quarters), ZVSA's Enterprise Value was at its highest in in the March 2026 quarter at 2.52B. The Enterprise Value was at its lowest in in the December 2024 quarter at -380506.00.
Average
172.73M
Median
86.21M
Minimum
-2251491.00
Maximum
697.39M
Discovering the peaks and valleys of ZyVersa Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.16%
Maximum Annual Enterprise Value = 697.39M
Minimum Annual Increase = -196942.22%
Minimum Annual Enterprise Value = -2251491.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 697.39M | -196942.22% |
| 2024 | -354289.02 | -84.26% |
| 2023 | -2251491.00 | -126.64% |
| 2022 | 8.45M | -95.00% |
| 2021 | 169.15M | 3.16% |
The current Enterprise Value of ZyVersa Therapeutics, Inc. (ZVSA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
231.59M
5-year avg
174.48M
10-year avg
172.73M
ZyVersa Therapeutics, Inc.’s Enterprise Value is greater than Hepion Pharmaceuticals, Inc. (-1997107.00), less than CDT Equity Inc. (1.08B), greater than Enveric Biosciences, Inc. (-3995341.00), greater than Longevity Health Holdings Inc. (460.35K), greater than NewGenIvf Group Limited (4.42M), greater than SCWorx Corp. (-1038316.00), greater than Indaptus Therapeutics, Inc. (4.77M), greater than Jasper Therapeutics, Inc. (-5949824.00), greater than Onconetix, Inc. (-3085440.00), greater than Silexion Therapeutics Ltd. (-665546.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -1997107.00 | $605.47K | |
| 1.08B | $3.38M | |
| -3995341.00 | $913.43K | |
| 460.35K | $373.13K | |
| 4.42M | $318.84K | |
| -1038316.00 | $303.46K | |
| 4.77M | $6.27M | |
| -5949824.00 | $7.44M | |
| -3085440.00 | $340.71K | |
| -665546.00 | $1.31M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ZyVersa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ZyVersa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ZyVersa Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA)?
What is the 3-year average Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA)?
What is the 5-year average Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA)?
How does the current Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA) compare to its historical average?